Gurevičienė G. PD-L1 INHIBITOR ATEZOLIZUMAB▼ - FOR NSCLC TREATMENT AFTER PRIOR CHEMOTHERAPY [Internet]. PIA 2020 Sep.;3(1):102-108.[cited 2024 May 19 ] Available from: http://pia.pulmoalerg.lt/index.php/PIA/article/view/154